Immune

Developing, funding and conducting clinical trials in immune tolerance

Share This
Home

For people with T1D who were previously enrolled in an ITN clinical study.

 

T1DES is currently enrolling study participants.

  • Home
  • About Type 1 Diabetes
  • About T1DES
  • Am I Eligible?
  • Study Locations

Other T1D Trials

Additional Type 1 Diabetes Research Studies Being Conducted by the ITN

EXTEND Preserving Beta-Cell Function with Tocilizumab in New-Onset Type 1 Diabetes

The EXTEND study is a clinical research study testing whether tocilizumab (Actemra ®) can protect remaining beta cells in individuals recently diagnosed with type 1 diabetes and extend the ability to naturally produce insulin.

For more information about the ITN and other clinical trials, please visit immunetolerance.org.

  • About ITN
  • Other T1D Trials
  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials
NIH   

T1DES is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded), with support from JDRF.

  • Home
  • About Type 1 Diabetes
  • About T1DES
  • Am I Eligible?
  • Study Locations
  • About ITN
  • Other T1D Trials
  • Children & Clinical Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials